Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Adaptimmune Therapeutics Plc

Adaptimmune Therapeutics Plc

ADAP · NASDAQ
ADAP · NASDAQ

Next Earnings: 14 May 2025

0.24
USD-0.00-0.37%

Latest News

    @eWhispers
    eWhispers

    Friday morning #earnings https://t.co/lObOE0dgsr $IMPL $ADAP $SPB $CPG $DCTH $CAAS $EMBC $NYC $AUGX $DDL $RGF $AIRS $HUMA $BPTH $LGVN $ACXP $BFRI $SHCO $AGIL https://t.co/6f63NZFowI

      @bitcoinagile
      bitcoinagile

      ADRs End Higher, Argo #blockchain and Adaptimmune Therapeutics Trade Actively #crypto https://t.co/UFrmrbCHWP https://t.co/vnKLy8YIsc

        @cryptomocho
        cryptomocho

        added only bio stunks to my porfolio and tesla $NTLA $BEAM $CRSP $EDIT $VERV $DNA $ADAP and my bigest one $intx https://t.co/jy9Q2ROAnB

        Analysts Recommendations

        Bullish

        Buy

        Strong Buy

        Buy

        Hold

        Sell

        Strong Sell

        Day Range

        0.24USD
        0.27USD

        52 Week Range

        0.20USD
        1.48USD

        Market Cap

        62.3MUSD

        lock-imagelock-image

        Get Full Access with Profit PRO

        See which Billionaires own this investment

        About

        General Information

        Type

        Common Stock

        Exchange

        NASDAQ

        Currency Code

        USD

        Currency Name

        US Dollar

        Country Name

        USA

        Country ISO

        US

        ISIN

        US00653A1079

        CUSIP

        00653A107

        Sector

        Healthcare

        Industry

        Biotechnology

        Fiscal Year End

        December

        IPO date

        -

        Updated At

        -

        Highlights

        PE Ratio

        -

        PEG Ratio

        0.11

        Book Value

        0.05

        Dividend Share

        -

        Dividend Yield

        -

        Earnings Share

        -0.3

        Wall Street Target Price

        1.71

        EPS Estimate Current Year

        -0.49

        EPS Estimate Next Year

        -0.49

        EPS Estimate Current Quarter

        -0.154

        EPS Estimate Next Quarter

        0

        Most Recent Quarter

        -

        Profitability

        Revenue TTM

        178,032,000

        Gross Profit TTM

        28,902,000

        EBITDA

        -41,184,000

        Profit Margin

        -39.78%

        Return On Assets TTM

        -12.39%

        Return On Equity TTM

        -275.74%

        Revenue Per Share TTM

        0.706

        Qtly Revenue Growth YOY

        1294.80%

        Diluted Eps TTM

        -0.3

        Qtly Earnings Growth YOY

        0.00%

        Valuation

        Trailing PE

        0.00

        Forward PE

        0

        Price Sales TTM

        0.3885

        Price Book MRQ

        5.8374

        Enterprise Value Revenue

        0

        Enterprise Value EBITDA

        -1

        Peers analysis

        • UCB SA ADR
          UCBJYUCB SA ADR

          79.92

          2.22%
        • Alnylam Pharmaceuticals Inc
          ALNYAlnylam Pharmaceuticals Inc

          240.54

          1.59%
        • CSL Ltd
          CSLLYCSL Ltd

          76.44

          0.91%
        • Vertex Pharmaceuticals Inc
          VRTXVertex Pharmaceuticals Inc

          491.92

          0.32%
        • Regeneron Pharmaceuticals Inc
          REGNRegeneron Pharmaceuticals Inc

          587.35

          0.23%
        • argenx SE
          ARGNFargenx SE

          697.42

          0.00%
        • UCB SA
          UCBJFUCB SA

          150.70

          0.00%
        • Be
          ONCBeiGene, Ltd.

          249.23

          -1.33%
        • argenx NV ADR
          ARGXargenx NV ADR

          594.65

          -0.94%
        • CSL Limited
          CMXHFCSL Limited

          153.00

          -0.55%
        XM

        Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

        Trade with a Trusted, Award-Winning Broker.

        Trading involves risk. The value of investments may go up or down. Trade responsibly.

        FAQs

        What is Adaptimmune Therapeutics Plc stock price today?

        What is Adaptimmune Therapeutics Plc stock ticker?

        Is ADAP stock price going up?

        What is the analyst recommendation for ADAP?

        What is ADAP market cap?

        Does ADAP release financial reports?

        When is ADAP next earnings date?

        What were ADAP Earnings for the last quarter?

        What was ADAP Revenue for the last quarter?

        What was ADAP Net Income for the last quarter?

        Does ADAP pay dividends?

        How many employees does ADAP have?

        What is ADAP EBITDA?

        How to buy ADAP stocks?

        Should I invest in ADAP stock?